Search for: "Takeda Pharmaceuticals" Results 41 - 60 of 451
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Apr 2019, 9:59 pm by Patent Docs
Increases were notanle for Bristol Myers-Squibb and Takeda, while Sanofi and Gilead showed reduced sales. [read post]
4 Mar 2019, 11:45 am by Tom Lamb
We also required the drug manufacturer, Takeda Pharmaceuticals, to conduct a large postmarket clinical trial to evaluate the cardiovascular safety of Uloric.... [read post]
7 Feb 2019, 6:00 am by Monica Wong (Toronto)
The most prominent of these deals was the takeover of Shire plc by Takeda Pharmaceutical Company Limited. [read post]
23 Jan 2019, 6:12 pm by Stan Gibson
In a patent infringement action, Takeda Pharmaceuticals America, Inc., and Takeda Pharmaceuticals U.S.A., Inc. [read post]
14 Jan 2019, 11:22 am by Tom Lamb
In more detail, one condition of the 2009 Uloric drug approval was that a postmarketing safety study be conducted by Takeda Pharmaceuticals America, Inc. [read post]
12 Nov 2018, 8:00 am by Robert Kreisman
Related blog posts: $9 Billion Actos Damage Award Against Takeda and Lilly is Upheld Actos Trials Under Way in Illinois; Juries in California and Maryland Reach Verdicts Sports Supplement Maker Moves to Consolidate Hepatitis and Liver Injury Cases     [read post]
17 Aug 2018, 8:00 am by Robert Kreisman
Related blog posts: $9 Billion Actos Damage Award Against Takeda and Lilly is Upheld Sports Supplement Maker Moves to Consolidate Hepatitis and Liver Injury Cases Dietary Supplements Make Up 20% of Drug-Related Liver Injuries       [read post]
6 Aug 2018, 11:50 am by James Innocent
Developed by Takeda Pharmaceutical Company (Takeda) in the late 1990’s, pioglitazone (the main ingredient of Actos) was approved by the FDA in 1999 as a once-daily supplement to diet and exercise for the treatment and control of type 2 diabetes symptoms. [read post]
2 Jul 2018, 11:40 am by Tom Lamb
But a third study by the manufacturer, Takeda Pharmaceutical of Osaka, Japan, didn’t raise the same alarms. [read post]
2 Jul 2018, 11:40 am by Tom Lamb
But a third study by the manufacturer, Takeda Pharmaceutical of Osaka, Japan, didn’t raise the same alarms. [read post]
14 Dec 2017, 10:48 pm by GJEL
Actos diabetes drugs $2.4 billion In 2015, a federal judge in Louisiana reported that a Japanese drug company, Takeda Pharmaceutical, had agreed to pay $2.4 billion over claims that Takeda concealed the safety risks of its Actos diabetes drug before regulators warned that extended use could cause bladder cancer. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Bard in Q2 2017 helped increase the value of deals.[27] Takeda Pharmaceutical Company acquired ARIAD Pharmaceuticals Inc for $5.2 billion to expand its oncology business. [read post]
15 Nov 2017, 8:00 am by Robert Kreisman
District Court Rules That Attorney-Client Privilege Applied in Insurance Coverage Lawsuit $9 Billion Actos Damage Award Against Takeda and Lilly is Upheld $90 Million Settlement Paid by Pharmaceutical Company For Its Unfair and Deceptive Promotion of Diabetes Drug The post U.S. [read post]
16 Aug 2017, 11:08 am by Tom Lamb
All of the defendant pharmaceutical companies in those lawsuits opposed that first effort to set up a Multidistrict Litigation (MDL) for these cases. [read post]
1 May 2017, 8:00 am by Robert Kreisman
Related blog posts: $9 Billion Actos Damage Award Against Takeda and Lilly is Upheld $90 Million Settlement Paid by Pharmaceutical Company For Its Unfair and Deceptive Promotion of Diabetes Drug $124 Million Penalty to Stand Against the Drug Maker Janssen for the Drug Risperdal     [read post]
25 Apr 2017, 3:00 am by Robert Kreisman
Related blog posts: $124 Million Penalty to Stand Against the Drug Maker Janssen for the Drug Risperdal $90 Million Settlement Paid by Pharmaceutical Company For Its Unfair and Deceptive Promotion of Diabetes Drug $9 Billion Actos Damage Award Against Takeda and Lilly is Upheld       The post U.S. [read post]